News
-
-
-
-
-
-
REGULATED PRESS RELEASE
NFL BIOSCIENCES: CESTO II STUDY RESULTS
-
REGULATED PRESS RELEASE
MEDESIS PHARMA: 2023 FULL-YEAR BUSINESS AND EARNINGS
-
-
-
PRESS RELEASE
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights.
Affluent Medical announces availability of a prospectus for trading of 6,190,831 shares in connection with a capital increase without preferential subscription rights. The AMF-approved Prospectus includes details of the Capital Increase